Spotlight on Annals

Asthma, smoking history and staph aureus enterotoxin sensitization; and the effectiveness of bleach versus warm baths in children with significant atopic dermatitis


November 13, 2017

The November issue of the Annals of Allergy, Asthma and Immunology has a variety of features for our practicing clinician readers. There are features and information about many aspects of our specialty. There are two articles in particular that are worth mentioning.

Idiopathic CD4 lymphocytopenia; status of epinephrine auto injector development


October 23, 2017

As the month of October winds down, hopefully everyone has had an opportunity to read and utilize the information from the many articles in this month’s Annals of Allergy, Asthma and Immunology. I want to call to attention to two articles that are of very pragmatic value for practicing clinicians.

From immunoglobulin replacement to anaphylactic reactions in patients with mastocytosis


October 9, 2017

The October issue of the Annals of Allergy, Asthma and Immunology has many articles and features that should be of interest to our readers. We have published on a wide variety that will impact practice.

One such article is written by Mark Ballow, MD, FACAAI, and provides an excellent evidence-based overview of the pragmatic aspects of immunoglobulin replacement. He traces the history of immunoglobulin replacement technology from intramuscular injections to current subcutaneous therapy, and the evolution of dosing strategies including amount and frequency. This is all accomplished using a clinical case and is a must read for all who engage in Ig replacement.

Office-based eligibility for biologics and probiotic therapy for chronic urticaria


July 3, 2017

The July issue of the Annals of Allergy, Asthma and Immunology has a variety of features that should be interesting for our readers. I would like to call attention to two specific ones that I encourage you to read.

The first, authored by Enrico Heffler, MD, PhD and colleagues, sought to determine whether a point-of-service device that can provide a blood eosinophil count was accurate enough compared to a standard laboratory-based analyzer. The data suggest that the correlation between the two methodologies was very high. This could provide immediate, office based eligibility for the use of certain biologicals in patients with severe asthma requiring a qualifying blood eosinophil level.